These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. COMBINED VITRECTOMY WITH INTRAVITREAL DEXAMETHASONE IMPLANT FOR REFRACTORY MACULAR EDEMA SECONDARY TO DIABETIC RETINOPATHY, RETINAL VEIN OCCLUSION, AND NONINFECTIOUS POSTERIOR UVEITIS. Pang JP; Son G; Yoon YH; Kim JG; Lee JY Retina; 2020 Jan; 40(1):56-65. PubMed ID: 30312262 [TBL] [Abstract][Full Text] [Related]
3. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group. Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF; Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema. Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343 [TBL] [Abstract][Full Text] [Related]
5. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification. Sze AM; Luk FO; Yip TP; Lee GK; Chan CK Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857 [TBL] [Abstract][Full Text] [Related]
6. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study. Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA; BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664 [TBL] [Abstract][Full Text] [Related]
7. [A cost-effectiveness study of dexamethasone implants in macular edema]. Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes. Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587 [TBL] [Abstract][Full Text] [Related]
9. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J Retina; 2013; 33(7):1435-40. PubMed ID: 23514796 [TBL] [Abstract][Full Text] [Related]
10. Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion. Pichi F; Specchia C; Vitale L; Lembo A; Morara M; Veronese C; Ciardella AP; Nucci P Am J Ophthalmol; 2014 Mar; 157(3):607-15.e1. PubMed ID: 24528934 [TBL] [Abstract][Full Text] [Related]
11. Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis. Sella R; Oray M; Friling R; Umar L; Tugal-Tutkun I; Kramer M Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1777-82. PubMed ID: 26228441 [TBL] [Abstract][Full Text] [Related]
12. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM; Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341 [TBL] [Abstract][Full Text] [Related]
13. Monthly microperimetry (MP1) measurement of macular sensitivity after dexamethasone implantation (Ozurdex) in retinal vein occlusions. Winterhalter S; Vom Brocke GA; Klamann MK; Müller B; Joussen AM Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1873-82. PubMed ID: 25576170 [TBL] [Abstract][Full Text] [Related]
14. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239 [TBL] [Abstract][Full Text] [Related]
15. The Efficiency of Intravitreal Dexamethasone Implants in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion. Unsal E; Eltutar K; Sultan P; Gungel H J Ocul Pharmacol Ther; 2015; 31(6):350-6. PubMed ID: 26133058 [TBL] [Abstract][Full Text] [Related]
16. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function. Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638 [TBL] [Abstract][Full Text] [Related]